The most commonly recommended genetic tests for breast cancer include BRCA1 and BRCA2 gene testing. In addition, multi-gene breast cancer panels that screen for genes such as CJEK2, TP53 and PALB2 are also recommended. In certain cases, HER2 (ERBB2) amplification and PIK3CA mutation testing may also be advised to check for certain specific risks and guide targeted treatment options.

A BRCA1 and BRCA2 test helps detect inherited gene mutations that significantly increase the risk of breast and ovarian cancers. Although these tests do not confirm the presence of cancer, these tests help to identify genetically predisposed individuals. This further helps to guide early screening, advise preventive strategies and build targeted treatment plans for better disease management.

Germline mutation analysis detects inherited genetic changes that are present in all the cells of the body and can be passed down from parents to children. These mutations are responsible for certain hereditary cancers. On the other hand, somatic mutation analysis identifies gene alterations that occur only in tumor cells during a person’s lifetime. These findings help guide targeted therapy and treatment decisions.

A breast cancer genetic test should be taken if you have a personal or family history of breast, ovarian, pancreatic or prostate cancer - especially at a young age. One should also get this test if a close relative has a known BRCA1 or BRCA2 mutation or any gene change associated with increased breast cancer risk. A genetic counselor can guide you on the right time with a targeted treatment plan.

The price range for breast cancer genetic tests vary based on the type and scope of analysis. A BRCA1 and BRCA2 gene analysis ranges from ₹14,000, while a comprehensive multi-gene breast cancer panel or advanced genomic profiling tests can go up to ₹50,000. The extra cost depends on whether the test involves germline or somatic analysis and the number of genes included in the panel.

The test results for breast cancer-related genetic and molecular tests at LifeCell Diagnostics vary by test type. Certain tests like the FISH for ERBB2 (HER2/neu) Amplification give reports within 6 days, BRCA1 & BRCA2 (Somatic) Extended Mutation Analysis test results can be expected within 16 days, BRCA1 & BRCA2 Gene Analysis (Germline) test results can be received within 21 days, while Comprehensive Panels like the Breast Cancer Gene Panel, etc., can be received within 22 days.

A doctor’s prescription is not mandatory for breast cancer genetic testing. It is, however, recommended to consult a doctor or a genetic counselor to ensure you choose the right test based on your family and personal history, and receive proper guidance on the preventive or targeted treatment.

A hereditary cancer gene panel helps identify inherited genetic mutations that increase the risk of developing cancers such as breast, ovarian, pancreatic, prostate and colon cancer. The benefits include early detection of genetic risk, personalised treatment plans and enabling proactive health management and timely medical decisions.

LifeCell Diagnostics’ breast cancer genetic tests are highly accurate and reliable, as they are performed using advanced next-generation sequencing (NGS) technology and strict quality control procedures. However, it is essential to recognise that even the most accurate genetic tests may not detect every possible gene mutation and do not guarantee that cancer will or will not develop. These tests should be interpreted in conjunction with a comprehensive risk assessment conducted under the guidance of a doctor.

Yes, you can book a breast cancer–related genetic test online with LifeCell Diagnostics. Once booked, a trained lab technician will collect your sample from the comfort of your home. Your sample will then be processed in our state-of-the-art laboratory, where we maintain the strictest standards of accuracy and reliability.